Nandrolone 17beta-carbonates

Details for Australian Patent Application No. 2006211907 (hide)

Owner Government of the United States of America, represented by The Secretary, Department of Health and Human Services

Inventors Kim, Hyun K.; Blye, Richard P.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006211907

PCT Pub. Number WO2006/083618

Priority 60/650,376 04.02.05 US

Filing date 24 January 2006

Wipo publication date 10 August 2006

Acceptance publication date 8 September 2011

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083618 Priority application(s): WO2006/083618

8 September 2011 Application Accepted

  Published as AU-B-2006211907

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006211960-Compositions and methods involving MDA-7 for the treatment of cancer

2006211884-Method for manufacturing material for oxide superconductor, method for manufacturing oxide superconducting wire rod, and superconducting device